![MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis | npj Breast Cancer MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-022-00475-1/MediaObjects/41523_2022_475_Fig1_HTML.png)
MRI to assess response after neoadjuvant chemotherapy in breast cancer subtypes: a systematic review and meta-analysis | npj Breast Cancer
![Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 10 (2017) Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 10 (2017)](https://jnccn.org/view/journals/jnccn/15/10/full-1216fig04.jpeg)
Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 10 (2017)
![Cancers | Free Full-Text | Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer Cancers | Free Full-Text | Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer](https://www.mdpi.com/cancers/cancers-14-05467/article_deploy/html/images/cancers-14-05467-g001.png)
Cancers | Free Full-Text | Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
![PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2a5cff93f34ad2baa7b2ce48db639064f71d844d/5-Table3-1.png)
PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar
![Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer - Advances in Radiation Oncology Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer - Advances in Radiation Oncology](https://advancesradonc.com/cms/attachment/3501bf5d-00bd-4da5-bdd9-8a803ef77d82/gr1.jpg)
Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer - Advances in Radiation Oncology
![Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges - Annals of Oncology Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/feb89e2f-7a4a-4eeb-b6fc-b1caf5a359af/gr3.jpg)
Eliminating the breast cancer surgery paradigm after neoadjuvant systemic therapy: current evidence and future challenges - Annals of Oncology
![Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/asset/32e9db11-f570-4d13-b53a-f0f642d88d11/gr1.jpg)
Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis - eClinicalMedicine
![Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer | SpringerLink Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-021-09994-w/MediaObjects/10434_2021_9994_Figa_HTML.png)
Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer | SpringerLink
![Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients - Annals of Oncology Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/b574d1ac-66df-4755-9a52-056e7abdae4f/gr1.jpg)
Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients - Annals of Oncology
![Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy | Scientific Reports Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-04032-x/MediaObjects/41598_2021_4032_Fig1_HTML.png)
Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy | Scientific Reports
![Survival outcome after liver metastasis surgery. Kaplan-Meier estimates... | Download Scientific Diagram Survival outcome after liver metastasis surgery. Kaplan-Meier estimates... | Download Scientific Diagram](https://www.researchgate.net/publication/318537238/figure/fig4/AS:614028762161154@1523407273137/Survival-outcome-after-liver-metastasis-surgery-Kaplan-Meier-estimates-comparing-overall.png)
Survival outcome after liver metastasis surgery. Kaplan-Meier estimates... | Download Scientific Diagram
![JPM | Free Full-Text | Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment JPM | Free Full-Text | Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment](https://www.mdpi.com/jpm/jpm-11-00172/article_deploy/html/images/jpm-11-00172-g001.png)
JPM | Free Full-Text | Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment
![Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors | SpringerLink Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-020-09214-x/MediaObjects/10434_2020_9214_Fig2_HTML.png)
Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors | SpringerLink
![Cureus | Role of Neoadjuvant Chemotherapy in Locally Advanced Carcinoma Stomach: An Analysis of the Short-Term Outcomes | Article Cureus | Role of Neoadjuvant Chemotherapy in Locally Advanced Carcinoma Stomach: An Analysis of the Short-Term Outcomes | Article](https://assets.cureus.com/uploads/figure/file/354088/lightbox_4213d030b05b11ecb54ad318665c4f09-Figure-1.png)
Cureus | Role of Neoadjuvant Chemotherapy in Locally Advanced Carcinoma Stomach: An Analysis of the Short-Term Outcomes | Article
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/aebe7284-f489-4fa5-a13d-db5ed5bcba73/gr2_lrg.jpg)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/34b2410d-db54-46e1-ac1d-1d1894292938/gr1_lrg.gif)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer - eClinicalMedicine Comparing outcomes following total neoadjuvant therapy and following neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer - eClinicalMedicine](https://www.thelancet.com/cms/attachment/4cf1fa16-f743-4d81-9b1e-60caf5259c4e/gr1_lrg.jpg)